Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MAST trial of anti-epileptic treatment strategies after traumatic brain injury
ISRCTN13200656Phase 3Completed
- Sponsor
- Cambridge University Hospitals NHS Foundation Trust
- Start
- Mar 2021
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, open-label trial of phenytoin and levetiracetam in Post-traumatic seizures (PTS) and traumatic brain injury (TBI), sponsored by Cambridge University Hospitals NHS Foundation Trust. Primary endpoints: Occurrence of late post-traumatic seizures and Occurrence of post-traumatic seizures. Started Mar 2021; status: completed.
02
Drugs
phenytoinlevetiracetam
03
Conditions
Post-traumatic seizures (PTS)traumatic brain injury (TBI)
Beyond the preview
Go deeper on ISRCTN13200656.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN13200656.